Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases.

Not Applicable

Recruiting

• Conditions: painful spinal bone metastases

• Registration Number: JPRN-UMIN000036849
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-01
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Not provided

Exclusion Criteria

1. The lesion is radiosensitive tumor 2. Need to surgical intervention due to spinal cord compression 3. Radiation history in same area within 3 months 4. Stereotactic body radiation therapy history in same area 5. Serious medical or psychological problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain progression-free rate at 6 months